Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-035659
Filing Date
2025-03-07
Accepted
2025-03-07 17:00:33
Documents
1
Period of Report
2025-03-05

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1434
  Complete submission text file 0000950170-25-035659.txt   2868
Mailing Address C/O BAKER BROTHERS INVESTMENTS 667 MADISON AVENUE, 21ST FLOOR NEW YORK NY 10065
Business Address
GOLLER MICHAEL (Reporting) CIK: 0001664389 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38596 | Film No.: 25721003

Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Issuer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)